APR 06, 2021 7:30 AM PDT

Radioactive Antibody Illuminates Fungal Lung Infections

WRITTEN BY: Tara Fernandez


 

An international team of scientists has pioneered a new procedure to diagnose lung disease caused by common mold. In immunocompromised individuals, the condition known as pulmonary aspergillosis can be life-threatening. With this groundbreaking new technology, physicians can detect the fungal disease faster, more precisely, and in a non-invasive manner for the first time.

We constantly breathe in Aspergillus’ air-borne spores, an abundant environmental mold commonly found in soil and decomposing plant material. For healthy individuals, the immune system destroys these spores before they can cause problems.

However, the fungus is an opportunistic pathogen in those with weakened immune systems, such as those battling underlying health conditions or chemotherapy patients. These individuals are at high risk of developing invasive pulmonary aspergillosis, an infection that can progress rapidly and is frequently fatal. This infection has posed a particular problem for COVID-19 patients in ICU—around a third of them end up developing pulmonary aspergillosis.

Positively diagnosing the disease takes a toll on patients. The current diagnostic standard is a highly invasive technique wherein fluid is injected into the lungs via the nose, and this fluid is then tested for the presence of spores.

Researchers at the University of Exeter have developed the next generation of aspergillosis diagnostics: a humanized Aspergillus-specific monoclonal antibody linked to a radiotracer, known as JF5. This antibody is administered into the bloodstream and targets the Aspergillus. It can be imaged using 3-dimensional microscopy techniques. This technique also allows physicians to monitor the performance of front-line antifungal drugs after a positive diagnosis.

This highly innovative and ground-breaking diagnostic technology is a step-change in the way we diagnose this devastating disease of immunocompromised patients, eliminating our current reliance on unpleasant invasive procedures," said Chris Thornton, the research lead.

While JF5 was validated in animal models, the researchers are confident that it will perform effectively in humans. The team is planning on conducting clinical trials to demonstrate JF5’s full clinical potential before commercializing the technology.

 

Sources: News Medical via University of Exeter, Nature Communications.

 


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 05, 2021
Clinical & Molecular DX
Wearable Patch Senses Blood Vessel Blockages
AUG 05, 2021
Wearable Patch Senses Blood Vessel Blockages
The cardiovascular system is like a network of highways, filled with an estimated 25 trillion red blood cells that conti ...
AUG 05, 2021
Clinical & Molecular DX
Gene Markers in Mothers Point to the Risk of Preterm Birth
AUG 05, 2021
Gene Markers in Mothers Point to the Risk of Preterm Birth
Preterm births—when the baby is born fewer than 37 weeks gestational age—are very common. Experts estimate o ...
SEP 01, 2021
Clinical & Molecular DX
Will Childhood Cancer Survivors Go On to Have Broken Hearts?
SEP 01, 2021
Will Childhood Cancer Survivors Go On to Have Broken Hearts?
Patients are seven times more likely to have a heart attack or stroke than the general population after receiving treatm ...
SEP 05, 2021
Microbiology
Gut Bacteria May Influence Infant Brain Development
SEP 05, 2021
Gut Bacteria May Influence Infant Brain Development
Our health is closely connected to the community of microbes we carry in our gut. For example, these microbes have a pow ...
NOV 11, 2021
Cancer
US Military Veterans: Cancer Risk and Cancer Research
NOV 11, 2021
US Military Veterans: Cancer Risk and Cancer Research
The US Department of Veteran’s Affairs (VA) estimates about 50,000 new cancer cases diagnosed each year. In total, ...
NOV 25, 2021
Cardiology
Who is at Risk for Postoperative Delirium After Cardiac Procedures?
NOV 25, 2021
Who is at Risk for Postoperative Delirium After Cardiac Procedures?
With the advancement of medical technology, the percentage of older adults undergoing operative procedures is increasing ...
Loading Comments...